文献速递头颈外科

局部晚期口咽癌:原发手术与原发放疗的生存比较

Primary surgery versus primary radiation-based treatment for locally advanced oropharyngeal cancer.
PubMed 文献 · Laryngoscope · 2017-10-08

该研究基于美国国家癌症数据库2004-2013年数据,纳入22,676例III-IV期局部晚期口咽癌患者,比较原发手术联合辅助放疗(±化疗)与原发放化疗的生存结局。中位随访40.7个月,手术组3年生存率85.4%,放化疗组72.6%(P<0.0001)。多因素校正后,手术组死亡风险显著降低(HR 0.79,95%CI 0.69-0.91,P=0.001)。

要点

  • 局部晚期口咽癌原发手术联合辅助放疗±化疗较原发放化疗生存更优
  • 校正HPV状态等多因素后手术组死亡风险仍显著降低(HR 0.79)
  • 缺乏随机对照数据,本研究为回顾性数据库分析(证据等级2c)

核心结论

  • 局部晚期口咽癌原发手术联合辅助放疗±化疗较原发放化疗改善生存,即使按HPV状态分层仍成立。

研究设计与样本

  • 回顾性队列研究,利用美国国家癌症数据库2004-2013年数据,纳入22,676例III-IV期局部晚期口咽癌患者。
  • 手术组8,555例接受手术联合辅助放疗±化疗,放化疗组14,121例接受原发放化疗。
  • 采用Kaplan-Meier法估计生存率,Cox回归模型计算粗风险比与校正风险比。

主要发现

  • 中位随访40.7个月,手术组3年生存率85.4%,放化疗组72.6%(P<0.0001)。
  • 多因素校正年龄、性别、种族、保险状态、收入、教育程度、Charlson-Deyo评分、临床T和N分期、肿瘤分级、机构类型、多机构治疗及HPV状态后,手术组死亡风险降低(HR 0.79,95%CI 0.69-0.91,P=0.001)。

临床怎么用

  • 对于局部晚期口咽癌,原发手术联合辅助放疗±化疗可作为改善生存的治疗选择,尤其在与患者充分讨论后。
  • 该结果为回顾性数据库证据(等级2c),临床决策需结合患者具体情况及缺乏随机对照数据的局限性。

局限性

  • 缺乏随机对照数据,研究为回顾性数据库分析。
  • 证据等级为2c,可能存在选择偏倚和混杂因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Randomized data comparing surgery to radiation for locally advanced oropharyngeal cancer (OPC) are lacking. This study evaluated practice patterns and overall survival outcomes from the National Cancer Database. METHODS: A total of 22,676 patients with stage III to IV, locally advanced OPC were treated between 2004 to 2013 with primary chemoradiation (CRT) or surgery with adjuvant radiotherapy with or without chemotherapy (aRT ± CT). Survival rates were estimated using the Kaplan-Meier method. Crude and adjusted hazard ratios (HR) were computed using Cox regression modeling. RESULTS: Median follow-up was 40.7 months; 8,555 and 14,121 patients received surgery with aRT ± CT and CRT, respectively. Corresponding 3-year survival was 85.4% and 72.6% (P < 0.0001). On multivariate analysis, adjusting for age, gender, race insurance status, median income, percentage with no high-school degree, Charlson-Deyo score, clinical tumor and node stage, tumor grade, facility type, treatment at > 1 facility, and human papillomavirus (HPV) status, surgery with aRT ± CT had a reduced hazard of death, HR, 0.79 (95% confidence interval 0.69-0.91), P = 0.001. CONCLUSION: Primary surgery with aRT ± CT for locally advanced OPC has an improved survival compared to primary radiation-based treatment even when stratified by HPV status. LEVEL OF EVIDENCE: 2c. Laryngoscope, 128:1353-1364, 2018.

来源:Laryngoscope,查看原文。版权归原作者所有。

引用

  1. Kamran SC, Qureshi MM, Jalisi S, et al. Primary surgery versus primary radiation-based treatment for locally advanced oropharyngeal cancer. Laryngoscope. 2017. PMID: 28988426. doi:10.1002/lary.26903

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。